Effect of Sildenafil on Endothelial Function

NCT00297544

Last updated date
Study Location
Rambam Medical Center, Recanati Autonomic Dysfunction CTR
Haifa, , 31096, Israel
Contact
972-4-854-2467

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

By phone

Pfizer Clinical Trials Contact Center

972-4-854-2467

By email

Contact

[email protected]

Call Now

Eligibility Criteria
condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Impotence
Sex
Male
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
40-70 years
Inclusion Criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- age 40-70

- impotence

- with and without hypertension, Hypercholesteremia or DM

Exclusion Criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details


- CHF: NYHA > II


- Stable angina: CCS > II


- Nitrate treatment

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

TRY A NEW SEARCH

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

ImpotenceEffect of Sildenafil on Endothelial Function
NCT00297544
  1. Haifa,
Male
40 Years+
years
MULTIPLE SITES
ImpotenceEvaluation of the Index of Sexual Life Questionnaire
NCT00245596
  1. Amphion-Les-Bains,
  2. Bordeaux,
  3. La Rochelle,
  4. Lille,
  5. Lyon Cedex 03,
  6. Lyon,
  7. PARIS Cedex 13,
  8. Paris,
  9. Saint-Emilion,
  10. Thionville,
  11. Toulouse,
Male
18 Years+
years
MULTIPLE SITES
ImpotenceA Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses
NCT00273416
  1. Oslo,
  2. Belfast, Northern Ireland
Male
18 Years+
years
MULTIPLE SITES
Advanced Information
Descriptive Information
Brief Title  ICMJE Effect of Sildenafil on Endothelial Function
Official Title  ICMJE Effect of Sildenafil on Endothelial Function
Brief Summary We are investigating the chronic effect of daily assumption of Viagra on the blood vessels function in patients with impotence. The study will include 2 groups: 1- patients with multiple risk factors, e.g. hypertension 2- patients with no cardiovascular risk factors
Detailed Description We are investigating the chronic effect of daily assumption of Viagra on the blood vessels function in patients with impotence. The study will include 2 groups: 1- patients with multiple risk factors, e.g. hypertension 2- patients with no cardiovascular risk factors
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Educational/Counseling/Training
Condition  ICMJE Impotence
Intervention  ICMJE Drug: Viagra
Study Arms  ICMJE Not Provided
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Unknown status
Enrollment  ICMJE
 (submitted: February 27, 2006)
60
Original Enrollment  ICMJE Same as current
Study Completion Date  ICMJE Not Provided
Primary Completion Date Not Provided
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • age 40-70
  • impotence
  • with and without hypertension, Hypercholesteremia or DM

Exclusion Criteria:

  • CHF: NYHA > II
  • Stable angina: CCS > II
  • Nitrate treatment
Sex/Gender  ICMJE
Sexes Eligible for Study:Male
Ages  ICMJE 40 Years to 70 Years   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Israel
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT00297544
Other Study ID Numbers  ICMJE 1777-CTIL
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE Not Provided
Responsible Party Not Provided
Study Sponsor  ICMJE Rambam Health Care Campus
Collaborators  ICMJE Pfizer
Investigators  ICMJE
Principal Investigator:Giris Jacob, Prof, MD, DScRambam Health Care Campus
PRS Account Rambam Health Care Campus
Verification Date November 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP